United States · FDA National Drug Code directory
Yargesa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42799-709_462f6c9d-b8f1-3a76-e063-6294a90a2b50
- Product NDC
- 42799-709
- Form
- CAPSULE
- Composition / generic term
- Miglustat
- Labeler
- Edenbridge Pharmaceuticals LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200806
- Source listing expiry
- 20261231
Source-listed ingredients
- MIGLUSTAT — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (42799-709-15) / 15 CAPSULE in 1 BLISTER PACK · 42799-709-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →